Monte Rosa Therapeutics Inc.

26/07/2024 | Press release | Distributed by Public on 26/07/2024 22:27

Trends in Immunology - VAV1 as a Putative Therapeutic Target in Autoimmune and Chronic Inflammatory Diseases